Skip to main content

MoneyWorks4Me

Jenburkt Pharmaceuticals informs about disclosure

22 Dec 2022 Evaluate

Jenburkt Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Mahesh H Bhuta, Jagruti Ketan Bhuta, Riddhi Haresh Shroff, Prakash H Bhuta & PACs.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1897.80
Dr. Reddys Labs. 1375.85
Cipla 1414.80
Lupin 2016.50
Zydus Lifesciences 1203.65
View more..